
Zgodnie z informacjami NCBiR projekty zgłaszane do konkursu muszą dotyczyć badań z następującego zakresu:
- Combined multi-omics approaches that complement genomics-based gene discovery strategies and that are driven by a lead hypothesis.
- Functional validation of clinical or biological inferences obtained from “-omics” results.
- Application of “-omics” approaches to rare diseases for which the gene(s) is/are known to enable insight into disease pathophysiology.
- Development and application of concepts and methods for pathogenic read-outs of disease groups which can be used as “blue print” to discover new disease genes and inform pathomechanism.
Szczegółowe informacje o konkursie można znaleźć na stronie internetowej Narodowego Centrum Badań i Rozwoju.